MX2015009504A - Desloratadine-based pharmaceutical composition to be orally administered, for the treatment of histamine related diseases.
- Google Patents
Desloratadine-based pharmaceutical composition to be orally administered, for the treatment of histamine related diseases.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C VfiledCriticalLaboratorios Liomont S A De C V
Priority to MX2015009504ApriorityCriticalpatent/MX2015009504A/en
Publication of MX2015009504ApublicationCriticalpatent/MX2015009504A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present disclosure is related to a pharmaceutical composition to be orally administered and also to be used for the treatment of histamine related diseases; without the use of both, lactose and disintegrant, and with the addition of a pharmaceutically acceptable agent to protect desloratadine.
MX2015009504A2015-07-232015-07-23Desloratadine-based pharmaceutical composition to be orally administered, for the treatment of histamine related diseases.
MX2015009504A
(en)
Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases.
Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical tablet or granular for the treatment of respiratory diseases.